Over the last 7 days, the United States market has risen 1.2%, and over the past 12 months, it is up by a notable 30%. In this promising environment where earnings are forecast to grow by 15% annually, identifying undervalued small-cap stocks with insider buying can present compelling opportunities for investors.
Name | PE | PS | Discount to Fair Value | Value Rating |
---|---|---|---|---|
Columbus McKinnon | 20.4x | 0.9x | 43.91% | ★★★★★★ |
Hanover Bancorp | 9.4x | 2.2x | 48.86% | ★★★★★☆ |
Citizens & Northern | 13.2x | 2.9x | 42.39% | ★★★★☆☆ |
MYR Group | 33.5x | 0.5x | 43.58% | ★★★★☆☆ |
Franklin Financial Services | 9.9x | 2.0x | 37.58% | ★★★★☆☆ |
Vital Energy | 4.3x | 0.6x | -48.01% | ★★★☆☆☆ |
Delek US Holdings | NA | 0.1x | -232.01% | ★★★☆☆☆ |
Community West Bancshares | 18.7x | 2.9x | 42.25% | ★★★☆☆☆ |
Orion Group Holdings | NA | 0.3x | -108.51% | ★★★☆☆☆ |
Industrial Logistics Properties Trust | NA | 0.7x | -253.37% | ★★★☆☆☆ |
Click here to see the full list of 51 stocks from our Undervalued US Small Caps With Insider Buying screener.
Let's dive into some prime choices out of from the screener.
Simply Wall St Value Rating: ★★★★★☆
Overview: Phibro Animal Health is a company that develops, manufactures, and markets a broad range of animal health and mineral nutrition products, with a market cap of approximately $0.57 billion.
Operations: Phibro Animal Health generates revenue primarily from three segments: Animal Health, Mineral Nutrition, and Performance Products. The company reported a gross profit margin of 30.82% for the quarter ending June 30, 2024. Operating expenses in the same period were $254.27 million, with non-operating expenses amounting to $56.93 million.
PE: 368.7x
Phibro Animal Health, a smaller U.S. company, has seen insider confidence with recent share purchases in the past quarter. Despite a dip in profit margins to 0.2% from 3.3% last year, earnings are forecasted to grow by 51.46% annually. Recent guidance for fiscal year 2025 projects net sales between US$1.04 billion and US$1.09 billion, driven by growth in its Animal Health segment and recovery in Mineral Nutrition and Performance Products segments.
Review our historical performance report to gain insights into Phibro Animal Health's's past performance.
Simply Wall St Value Rating: ★★★★★★
Overview: Columbus McKinnon is a company specializing in machinery and industrial equipment with operations generating approximately $1.02 billion in revenue.
Operations: Machinery & Industrial Equipment generated $1.02 billion in revenue for the latest period. Gross profit margin has shown an upward trend, reaching 37.08% recently.
PE: 20.4x
Columbus McKinnon, a smaller U.S. company, has shown potential for growth with earnings forecast to increase by 29.84% annually. Despite the recent executive change with Jon Adams stepping in as President of Americas post-September 2024, the company remains steady. They reported Q1 sales of US$239.73 million and net income of US$8.63 million, slightly down from last year’s figures but still solid performance indicators. Insider confidence is evident through share purchases within the past six months, reflecting optimism about future prospects despite current financial challenges like high-risk funding sources and modest dividend payouts at $0.07 per share.
Evaluate Columbus McKinnon's historical performance by accessing our past performance report.
Simply Wall St Value Rating: ★★★★★☆
Overview: PRA Group is a financial services company specializing in the purchase and collection of nonperforming loans, with a market cap of approximately $1.42 billion.
Operations: The company generates revenue primarily from accounts receivable management, with operating expenses and non-operating expenses being significant cost components. Notably, the net income margin has shown fluctuations, reaching as high as 23.85% and dipping to -10.40% in recent periods.
PE: 217.6x
PRA Group's recent earnings report shows a significant turnaround, with Q2 2024 revenue at US$284.23 million, up from US$209.24 million the previous year, and net income of US$21.52 million compared to a net loss of US$3.8 million a year ago. Insider confidence is evident as Independent Director Geir Olsen purchased 11,750 shares worth approximately US$251,332 in June 2024, increasing their holdings by over 250%. This activity suggests optimism about the company's future performance despite its recent drop from several Russell indexes and board changes.
Examine PRA Group's past performance report to understand how it has performed in the past.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGM:PAHC NasdaqGS:CMCO and NasdaqGS:PRAA.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.